Nanomedicine

Papers
(The H4-Index of Nanomedicine is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Immunogenicity of trivalent DNA vaccine candidate encapsulated in Chitosan-TPP nanoparticles against EV-A71 and CV-A16191
Intraductal Delivery of Nanocarriers for Ductal Carcinoma In Situ Treatment: A Strategy to Enhance Localized Delivery70
Therapeutic Targets and Nanomaterial-Based Therapies for Mitigation of Secondary Injury After Spinal Cord Injury60
Bioresponsive Self-Illuminating Nanoparticles for Luminescence Imaging of Inflammation and Oxidative Stress60
Nanotechnology-Based Mucoadhesive and Mucus-Penetrating Drug-Delivery Systems for Transbuccal Drug Delivery59
Nanoparticles Integrated with Mild Photothermal Therapy and Oxaliplatin for Tumor cHemotherapy and Immunotherapy37
Limitations of Limulus amebocyte lysate test for endotoxin control in raw materials for liposomal nanoformulations34
Current views and trends of nanomaterials as vectors for gene delivery since the 21st century: a bibliometric analysis34
Multimodal Molecular Imaging in the Second Near-Infrared Window33
To heat or not to heat: the impact of temperature on the aggregation state of amphotericin B in drug delivery systems32
Considering the impact of the chirality of therapeutic nanoparticles on cancer therapy32
Simultaneous Multicolor Imaging of Lymph Node Chains Using Hydroporphyrin-Doped Near-Infrared-Emitting Polymer Dots32
Therapeutic Outcome of Quercetin Nanoparticles on Cerastes Cerastes Venom-Induced Hepatorenal Toxicity: A Preclinical Study29
Insights Into the Mapping of Green Synthesis Conditions for Zno Nanoparticles and their Toxicokinetics29
Statement of Retraction: Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer28
Nanotechnology in Adjuvants and Vaccine Development: What Should We Know?28
Assessing the efficacy of nanoparticles in reversing opioid poisoning and preventing renarcotization27
Human Solid Tumors and Clinical Relevance of The Enhanced Permeation and Retention Effect: A ‘Golden Gate’ for Nanomedicine in Preclinical Studies?26
MicroRNA-targeted nanoparticle delivery systems for cancer therapy: current status and future prospects26
Scaffold Biomaterials and Nano-Based Therapeutic Strategies for Skeletal Muscle Regeneration26
Enhanced Permeability and Retention Effect-Focused Tumor-Targeted Nanomedicines: Latest Trends, Obstacles and Future Perspective24
Nanotherapeutic Potential of Antibacterial Folic Acid-Functionalized Nanoceria for Wound-Healing Applications24
Cascade Biomimetic Intelligent Nanotheranostic Agents for Imaging-Guided Tumor Synergistic Therapy23
A Novel Gene Therapy for Neurodegenerative Lafora Disease Via Epm2A -Loaded Dlindma Lipoplexes23
Intranasal Administration of Molecular-Gated Mesoporous Nanoparticles to Increase Ponatinib Delivery to The Brain23
0.18426918983459